SOMOS, INC. – Trademark Portfolio
Entity Type: 03
SOMOS, INC. owns a portfolio of 54 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as SOMOS, S SOMOS, SOMOSID, REALAGENT, and REALBRAND. Of these, 22 are registered and 9 are pending. The portfolio spans 5 Nice Classification classes, led by Class 38 (Telecommunications) and Class 35 (Advertising & Business). Headquartered in BRIDGEWATER, NJ.
P.O. BOX 8122
BRIDGEWATER, NJ 08807
Showing of trademarks Trademarks
Trademark Classifications
SOMOS, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does SOMOS, INC. have?
SOMOS, INC. has 54 U.S. trademarks filed with the USPTO. Of these, 22 registered, 9 pending, 20 abandoned, 3 cancelled.
What trademark classes does SOMOS, INC. file in?
SOMOS, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 38 (Telecommunications), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 38 covers telecommunications.
What are SOMOS, INC.'s most well-known trademarks?
SOMOS, INC.'s registered trademark portfolio includes well-known marks such as SOMOS, S SOMOS, SOMOSID, REALAGENT, and REALBRAND. These are among 22 currently registered trademarks in the portfolio.
What is SOMOS, INC.'s trademark registration success rate?
SOMOS, INC. has a 49% trademark registration rate, with 22 out of 45 resolved applications resulting in successful registration. Currently, 9 applications are pending review.